Caption
Researcher in a laboratory
Funding boost for promising treatment
Date
Research news
Date
Results from a US study show that a hormone called irisin has the potential to halt the progression of Parkinson’s in mice.
Date
Scientists at the University of Manchester have developed a test which could help diagnose Parkinson’s in 3 minutes using a simple skin swab.
Date
The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.
Date
Over the next 3 years, the US-based Parkinson’s Foundation will invest a minimum of $3m (over £2.4m) into the Parkinson’s Virtual Biotech, our international drug discovery and development programme.
Date
2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson’s.
Date
We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
Date
An important research partnership involving Parkinson’s UK, pharmaceutical company UCB and the Parkinson’s Foundation has published their first results in a study designed alongside people living with Parkinson’s.
Date
Campaigners share their work and plan activities to improve Parkinson’s care
Date
We’re calling on the Parkinson’s community to take part in 5 important clinical studies that are currently at risk of closure.
Date
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.